Asahi Kasei Corporation (TSE1:3407, hereinafter: Asahi Kasei), Japan's
leading diversified chemical manufacturer with businesses in the health
care, chemicals & fibers, homes & construction materials, and
electronics sectors, announced today the successful completion of its
acquisition of ZOLL Medical Corporation (hereinafter: ZOLL), a major US
manufacturer of medical devices for critical care, on April 26, 2012, US
Eastern time.
On March 12, 2012, Asahi Kasei announced a tender offer for shares of
ZOLL, through a US subsidiary. All procedures related to this
acquisition were completed on April 26, 2012, US Eastern time, and ZOLL
became a wholly owned consolidated subsidiary of Asahi Kasei.
As a result, ZOLL's stock will cease to be traded on the NASDAQ market,
and ZOLL will no longer have reporting obligations under the Securities
Exchange Act of 1934. ZOLL will continue to be managed by its current
management team.
Up to 95 million Americans may rely on untreated groundwater containing PFAS for drinking water